| Company Name | Valiant Laboratories Limited |
| Open Date | 27-09-2023 |
| Close Date | 03-10-2023 |
| Exchange | BSE, NSE |
| Lot Size | 105 Shares |
| Issue Price | ₹ 133 to ₹ 140 per share |
| Issue Size | 1,08,90,000 Equity Shares |
| Application Amount | Min. Inv. - ₹ 14,700 (105 shares) Max. Inv. - ₹ 1,91,100 (1,365 shares) |
| Recommendation | Apply |
Valiant Laboratories Limited was originally incorporated in the year 1980 and has its registered office in Mumbai, Maharashtra.
The Company is an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The manufacturing facility is located at Maharashtra, India which is spread over an aggregate parcel of land and measuring about 2,000 sq. mts. The company also has an in-house R&D infrastructure equipped with analytical laboratory and infrastructure for developmental activities. As of 31st July 2023, the Company has 91 employees on its payroll.
| For the Period Ended | Mar-21 | Mar-22 | Mar-23 |
| Total Assets | 10,631.40 | 18,181.20 | 21,275.70 |
| Net Assets | 8,858.20 | 7,146.00 | 10,049.00 |
| Total Borrowings | 35.10 | 6,068.10 | 5,940.00 |
| Total Revenue | 18,378.10 | 29,347.20 | 33,877.30 |
| Profit After Tax | 3,059.30 | 2,749.70 | 2,899.90 |
| Opening Date | 27/09/2023 |
| Closing Date | 03-10-2023 |
| Basis of Allotment | 05-10-2023 |
| Initiation of Refunds | 06-10-2023 |
| Credit of Shares to Demat | 06-10-2023 |
| Listing Date | 09-10-2023 |
| Investment in its wholly owned subsidiary, for part- financing its capital expenditure (setting up of a manufacturing facility). |
| Working Capital Requirements. |
| General Corporate Purpose. |
| Registered Office | Valiant Laboratories Limited 104,Udyog Kshetra, Mulund Goregaon Link Road, Mulund West, Mumbai -400080 |
| Phone | +91 2249712001 |
| complianceofficer@valiantlabs.in | |
| Website | https://valiantlabs.in/ |
| Valiant Laboratories Limited DRHP |
| Valiant Laboratories Limited RHP |
| Name | Link Intime India Private Ltd |
| Phone | +91-22-4918 6270 |
| valiantlaboratories.ipo@linkintime.co.in | |
| Website | https://linkintime.co.in/mipo/ipoallotment.html |
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
| Share Holding Pre Issue (Promoters) | 100.00% |
| Share Holding Post Issue (Promoters) | 74.94% |